Consistent with the in vitro findings, in mice with intracranial orthotopic glioma transplantation, c‐Myc silencing significantly decreased the increase in cell growth resulting from NIBAN2 upregulation (Figure 6C). The gene discussed is MYC; the disease is central nervous system cancer.